Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571-Reference-Cited by-同舟云学术

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

Published:2000-07 Issue:31 Volume:19 Page:3521-3528
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Wang Wen-Lan,Healy Mary Ellen,Sattler Martin,Verma Shalini,Lin Jeffrey,Maulik Gautam,Stiles Charles D,Griffin James D,Johnson Bruce E,Salgia Ravi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1203698.pdf

Reference23 articles.

1. Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ and Lydon NB. . 1996 Cancer Res. 56: 100–104.

2. Carroll M, Ohno-Jones S, Tamura S, Buchdunger E, Zimmermann J, Lydon NB, Gilliland DG and Druker BJ. . 1997 Blood 90: 4947–4952.

3. Chaudhry A, Carrasquillo JA, Avis IL, Shuke N, Reynolds JC, Bartholomew R, Larson SM, Cuttitta F, Johnson BE and Mulshine JL. . 1999 Clin. Cancer Res. 5: 3385–3393.

4. Chute JP, Chen T, Feigal E, Simon R and Johnson BE. . 1999 J. Clin. Oncol. 17: 1794–1801.

5. DiPaola RS, Kuczynski WI, Onodera K, Ratajczak MZ, Hijiya N, Moore J and Gewirtz AM. . 1997 Cancer Gene Ther. 4: 176–182.

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights;OncoTargets and Therapy;2023-09

2. Targeting aloe active compounds to c-KIT promoter G-quadruplex and comparative study of their anti proliferative property;Journal of Biomolecular Structure and Dynamics;2022-11-15

3. Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer;International Journal of Molecular Sciences;2022-02-18

4. Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non‑randomized, single‑center study;Oncology Letters;2020-06-19

5. Imatinib modulates pro-inflammatory microenvironment with angiostatic effects in experimental lung carcinogenesis;Inflammopharmacology;2019-11-01